P515: LOWER-INTENSITY CPX-351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844948.28359.0b |
| _version_ | 1797287880248262656 |
|---|---|
| author | G. L. Uy V. A. Pullarkat P. Baratam R. K. Stuart R. B. Walter E. S. Winer S. Faderl V. Chandrasekaran Q. Wang D. Chakravarthy R. S. Cheung T. L. Lin |
| author_facet | G. L. Uy V. A. Pullarkat P. Baratam R. K. Stuart R. B. Walter E. S. Winer S. Faderl V. Chandrasekaran Q. Wang D. Chakravarthy R. S. Cheung T. L. Lin |
| author_sort | G. L. Uy |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:41:13Z |
| format | Article |
| id | doaj.art-1d6734d98fd64f94af76e9982186fdf8 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:41:13Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-1d6734d98fd64f94af76e9982186fdf82024-03-02T03:51:50ZengWileyHemaSphere2572-92412022-06-01641441510.1097/01.HS9.0000844948.28359.0b202206003-00414P515: LOWER-INTENSITY CPX-351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPYG. L. Uy0V. A. Pullarkat1P. Baratam2R. K. Stuart3R. B. Walter4E. S. Winer5S. Faderl6V. Chandrasekaran7Q. Wang8D. Chakravarthy9R. S. Cheung10T. L. Lin111 Washington University School of Medicine, St. Louis, MO2 City of Hope Comprehensive Cancer Center, Duarte, CA3 Medical University of South Carolina, Charleston, SC3 Medical University of South Carolina, Charleston, SC4 Fred Hutchinson Cancer Research Center, Seattle, WA5 Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA6 Jazz Pharmaceuticals, Palo Alto, CA6 Jazz Pharmaceuticals, Palo Alto, CA6 Jazz Pharmaceuticals, Palo Alto, CA6 Jazz Pharmaceuticals, Palo Alto, CA6 Jazz Pharmaceuticals, Palo Alto, CA7 University of Kansas Medical Center, Kansas City, KS, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000844948.28359.0b |
| spellingShingle | G. L. Uy V. A. Pullarkat P. Baratam R. K. Stuart R. B. Walter E. S. Winer S. Faderl V. Chandrasekaran Q. Wang D. Chakravarthy R. S. Cheung T. L. Lin P515: LOWER-INTENSITY CPX-351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY HemaSphere |
| title | P515: LOWER-INTENSITY CPX-351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY |
| title_full | P515: LOWER-INTENSITY CPX-351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY |
| title_fullStr | P515: LOWER-INTENSITY CPX-351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY |
| title_full_unstemmed | P515: LOWER-INTENSITY CPX-351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY |
| title_short | P515: LOWER-INTENSITY CPX-351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY |
| title_sort | p515 lower intensity cpx 351 venetoclax for patients with newly diagnosed acute myeloid leukemia who are unfit for intensive chemotherapy |
| url | http://journals.lww.com/10.1097/01.HS9.0000844948.28359.0b |
| work_keys_str_mv | AT gluy p515lowerintensitycpx351venetoclaxforpatientswithnewlydiagnosedacutemyeloidleukemiawhoareunfitforintensivechemotherapy AT vapullarkat p515lowerintensitycpx351venetoclaxforpatientswithnewlydiagnosedacutemyeloidleukemiawhoareunfitforintensivechemotherapy AT pbaratam p515lowerintensitycpx351venetoclaxforpatientswithnewlydiagnosedacutemyeloidleukemiawhoareunfitforintensivechemotherapy AT rkstuart p515lowerintensitycpx351venetoclaxforpatientswithnewlydiagnosedacutemyeloidleukemiawhoareunfitforintensivechemotherapy AT rbwalter p515lowerintensitycpx351venetoclaxforpatientswithnewlydiagnosedacutemyeloidleukemiawhoareunfitforintensivechemotherapy AT eswiner p515lowerintensitycpx351venetoclaxforpatientswithnewlydiagnosedacutemyeloidleukemiawhoareunfitforintensivechemotherapy AT sfaderl p515lowerintensitycpx351venetoclaxforpatientswithnewlydiagnosedacutemyeloidleukemiawhoareunfitforintensivechemotherapy AT vchandrasekaran p515lowerintensitycpx351venetoclaxforpatientswithnewlydiagnosedacutemyeloidleukemiawhoareunfitforintensivechemotherapy AT qwang p515lowerintensitycpx351venetoclaxforpatientswithnewlydiagnosedacutemyeloidleukemiawhoareunfitforintensivechemotherapy AT dchakravarthy p515lowerintensitycpx351venetoclaxforpatientswithnewlydiagnosedacutemyeloidleukemiawhoareunfitforintensivechemotherapy AT rscheung p515lowerintensitycpx351venetoclaxforpatientswithnewlydiagnosedacutemyeloidleukemiawhoareunfitforintensivechemotherapy AT tllin p515lowerintensitycpx351venetoclaxforpatientswithnewlydiagnosedacutemyeloidleukemiawhoareunfitforintensivechemotherapy |